Endocrine disturbances of calcium metabolism in uremia: Renal causes and systemic consequences. The genesis of the hormonal disturbances in calcium metabolism of renal failure is complex, but can be understood basically as the consequence of the deranged endocrine function of the kidney, that is, failing biosynthesis of the renal secosterol hormone 1,25 0H2D3. It is of interest to note how our concepts concerning the genesis of these disturbances, and the role of 1,25 0H2D3 therein, have changed with time. We illustrate this using three examples: (i) the signals activating the parathyroid gland in early renal failure; (ii) the genesis of parathyroid hyperplasia; and (iii) the actions of 1,25 0H7D5 in renal failure unrelated to calcium control.
extremely flattering to the nephrologist, is unfortunately not entirely correct. It serves to illustrate, however, that the concepts on the kidney's function have changed with time. One of the more fascinating recent developments is the recognition that, apart from its long-established exocrine function, the kidney has important endocrine functions as well, disturbances of which have important clinical repercussions.
In the following we shall discuss three topics illustrating the recent change of paradigms to explain disturbances in renal failure related to abnormal renal endocrine function, that is, biosynthesis of the secosterol hormone 1,25 0H2D3 (in the following called calcitriol).
The signal triggering secondary hyperparathyroidism in incipient renal failure Elevated levels of intact PTH are noted in a considerable proportion of renal patients with incipient renal failure, that is, GFR 60 to 80 ml/min [1] . This observation points to early hyperparathyroidism and raises the issue which signal is responsible for activation of the parathyroid gland. Two decades ago Neil Bricker proposed the following ingenious hypothesis ( Table 1) . As GFR decreases, serum phosphate concentration has a tendency to increase, at least post-prandially; the ensuing decreased levels of ionized calcium should trigger the release of PTH and thus © 1996 by the International Society of Nephrology increase phosphate clearance. The final result would be (near) normal serum phosphate concentrations at the price of elevated PTH concentrations. Hyperparathyroidism was thus felt to be a "trade-off" for the homeostasis of serum phosphate concentration [2] .
This hypothesis has proved very useful in stimulating many experiments, but it may not fully explain the findings in incipient renal failure. As shown in Figure 1 , the circadian profile of serum phosphate concentrations under baseline conditions and following a phosphate load was absolutely identical in patients with incipient renal failure and in healthy controls [3] . It may still be that serum phosphate concentrations are not an adequate reflection of the concentration of phosphate in some hypothetical subcellular (renal?) compartment involved in control of renal 1-a-hydroxylase activity, that is, the enzyme responsible for the generation of calcitriol. Despite various reports to the contrary [4] , when we placed patients with incipient renal failure on reduced phosphate intake [5] we failed to note a return of calcitriol concentrations into the normal range. These observations are difficult to reconcile with a crucial role of phosphate in the genesis of hyperparathyroidism in incipient renal failure. It goes without saying that a solid body of experimental and clinical evidence points to an important role of phosphate in hyperparathyroidism of advanced renal failure.
Moreover, recent in vivo evidence from experimental [6, 71 and clinical studies is even compatible with a direct stimulating role of phosphate on the parathyroids unrelated to ionized calcium and calcitriol. Nevertheless, it appears that an alternative, or at least complementary, explanation must be sought.
We have reasoned [8] that nephron loss or malfunction in incipient renal failure diminishes the activity of 1-a-hydroxylase, allowing the parathyroid to escape from negative feedback control (Fig. 2) . The increase in PTH activity would stimulate renal 1-a-hydroxylase activity and thus return calcitriol levels to the (near) normal range. As a final result calcitriol levels would be normal but at the price of elevated PTH concentration. It is quite obvious that a simple scheme as depicted in Figure 2 neglects a number of confounding factors which have become apparent recently: (i) the calcium receptor of the parathyroid that has recently been cloned [9] and may play a calcitriol-independent role; the behavior of the receptor during Ca depletion and renal failure is currently not well established [10] ; (ii) furthermore, recent studies, at least in advanced renal failure, are compatible with covalent modification and abnormal nuclear uptake of the vitamin D receptor [11] ; and finally, (iii) PTH receptors [12] and A negative feedback system can be tested dynamically by a step-change of an input variable. Lucas, Brown and Woodhead [141 examined plasma calcitriol levels in kidney donors who underwent unilateral nephrectomy. A consistent decrease of plasma calcitriol levels was noted. Levels returned to the normal range ( Fig. 3 ), but at the price of elevated PTH concentrations. Conversely, when exogenous 1,38 hPTH, that is, the aminoterminal fragment of the human PTH, was infused in patients with incipient renal failure, stimulation of renal biosynthesis of calcitriol, as reflected by the acute increase in calcitriol serum levels, was diminished in proportion to baseline PTH concentrations. It was most markedly diminished in those patients with the highest PTH levels [15] . This observation suggests that in incipient renal failure 1-a-hydroxylase is stimulated already to such a degree that it becomes relatively refractory to further stimulation by exogenous PTH.
Finally, a role for calcitriol deficiency is suggested by the following observation: reversal of parathyroid overactivity in patients with incipient renal failure following the administration of calcitriol [16] Genesis of parathyroid hyperplasia In the past it had been assumed that parathyroid hyperplasia was a regulatory phenomenon. Stimulation of parathyroid leads to (i) increased mRNA of pre-pro-PTH in individual parathyroid cells and (ii) recruitment of hormonally active parathyroid cells by parathyroid cell proliferation (parathyroid hyperplasia) (Fig. 2 ) [19] . The genesis of parathyroid hyperplasia is of great importance since it is poorly reversible; at least its reversal by apoptosis is an extremely slow process [20] . Experimental studies [21] document that parathyroid hyperplasia can easily be prevented but is difficult to reverse [21] . The mechanisms underlying parathyroid hyperplasia are therefore of obvious clinical relevance.
One striking observation is the fact that the relative risk of the dialysis patient to require parathyroidectomy increases dramatically with duration of dialysis [22] . Furthermore, staining of parathyroid cells for nuclear calcitriol receptors shows inhomogenous nuclear uptake of stain, regions with higher staining actually being juxtaposed to regions with low staining activity. This observation is compatible with the note that regions with low receptor expression escape from inhibition of proliferation by calcitriol receptor [21] . Recently, Fukuda et a! [23] documented that calcitriol receptor expression was lower in patients with advanced nodular than diffuse parathyroid hyperplasia.
That parathyroid hyperplasia is not exclusively a regulatory phenomenon has become apparent from a number of clinical observations, such as the high rate of local recurrence after parathydroidectomy [24] , the occurrence of locally invasive growth of parathyroid autotranspiants in forearms [25] , the risk being particularly high in grafts with DNA content outside the diploid range or in the presence of increased numbers of mitoses within the gland. All these abnormalities point to abnormal growth control.
It has recently become obvious that there is a molecular biological basis to abnormal parathyroid growth. Falchetti et al [26] reported on clonal allelic loss of genes on chromosome 11q13 coding for putative tumor suppressor genes [26] . Using X-chromosome inactivation analysis with the M27-J3-DNA polymorphism, Arnold et a! [27] demonstrated monoclonal growth in at least 64% of uremic patients with refractory hyperparathyroidism.
The gene(s) responsible for monoclonality has not been identified. Apparently, somatic mutations confer a growth advantage to clones of parathyroid cells thus causing monoclonal growth and nodular parathyroid hyperplasia (although the two phenomena are not strictly linked). It appears that in the hyperproliferative environment of the parathyroid gland such mutated cells proliferate in an uncontrolled fashion. This may be similar to the sequence of events that has been postulated in the genesis of papillary renal cell tumors of kidneys in end-stage renal failure [28] .
Actions of calcitriol unrelated to calcium homeostasis In the mammalian organism, calcitriol is crucial for the hormonal control of calcemia and calcium balance. It has become apparent, however, that calcitriol is a phylogenetically ancient substance that has actions on many non-classical target organs. Deficiency of calcitriol may therefore be relevant to the understanding of some aspects of uremia that are unrelated to calcium homeostasis [29] .
Following observations that cows ingesting a plant, Trisetum flavescens, develop hypercalcemia from vitamin D intoxication and are no longer able to produce milk, Zucker, Stark and Rambeck [30] were able to show UV light-dependent synthesis of cholecalciferol by Trisetum flavescens. Another plant species, Solanum malacoxylon, has even been shown to synthesize 1,25 0H2D3 [31] . Calcitriol affects cellular calcium concentration, it suppresses cell profileration and promotes cell differentiation, such as rhizogenesis [32] . Are these phylogenetically ancient actions relevant in humans [33] ? Ricketic children frequently die from infection; more recently, this found an explanation by the observation that calcitriol plays an important role in macrophage function and in immune regulation. Furthermore, ricketic children exhibit a vitamin D-dependent form of myopathy [34] . It is of note that painters in Northern countries, such as the Netherlands and Germany, depicted the Jesus Christ baby with a frog belly (a sign of ricketic myopathy), a feature which is consistently absent in illustrations of Italian painters living on the sunlit shores of the Mediterranean.
More recently, calcitriol receptors in, and calcitriol actions on a number of non-classical target tissues have been recognized, Kidney cx hydroxylase Six patients with incipient renal failure (Ce, 65 mllmin) and 6 healthy control (Cr0 148 mI/mm) were studied between 9 a.m. and 3 p.m. on the first day without (-) and on the second day with (---) an oral P load administered at 9 a.m. (1 g P170 kg given as Na-K-phosphate buffered atpH Z4 and dissolved in 100 ml water). Note no difference between the circadian profile in patients with renal failure and controls [3] . improved, for instance, immune functions and glucose-stimulated insulin secretion. One of the phylogenetically ancient functions of calcitriol is to suppress cell proliferation. This has been shown in renal carcinoma cells [35] and in normal renal cells, that is, compensatory Space does not permit an in depth discussion of these findings, but it is of note that in uremic patients administration of calcitriol growth after uninephrectomy [36] , mesangial cells [37] , and proximal tubular cell cultures [38] . Since glomerular growth is apparently a permissive factor which favors the genesis of glomerulosclerosis, the question arises whether such action of calcitriol can be harnessed to attenuate the development of glomerulosclerosis. This possibility is, indeed, suggested by preliminary studies which require further confirmation.
It appears then that calcitriol deficiency, and abnormalities of
